PATENT CLAIM ANALYSIS

Application Number: 15943236
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-04
Patent Classification: ["424", "464000"]

Abstract:
Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.

Claim (Index 16):
The dosage form of  claim 9 , wherein the opthalmically acceptable vehicle or carrier comprises a composition selected from the group consisting of water, phosphate buffered saline (pH 7.4), 0.15M aqueous sodium chloride solution and combinations thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14632089', '12707092', '13952028', '12686106', '15791290']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8235881769854231
- 35 USC 102 Novelty (BERT): 0.5569858466547868
- Combined Prediction Score: 0.7969279439523596
- Mean Citation Score: 417.100024
- Max Citation Score: 473.16202
- Similarity Product: 322.89435866210096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test